RRM2, KIF3A, and ALYREF were correlated with poor prognosis of HCC patients, while high expression of CPEB2, COLEC10, and PBLD was associated with better prognosis (p < 0.05; Fig. 4D). Here, PBLD is linked to hepatocellular carcinoma.